deltatrials
Unknown OBSERVATIONAL NCT05947786

Mpox Paediatric and Adolescent Clinical Study

Sponsor: European Commission

Updated 4 times since 2023 Last updated: Jul 7, 2023 Started: Mar 17, 2023 Primary completion: Jul 31, 2025 Completion: Jul 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Monkey Pox and Monkeypox, this trial is ongoing. The trial is conducted by European Commission and has accumulated 4 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Aug 2023 – ~Jul 2024 · 11 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotRecruiting~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

4 versions recorded
  1. Sep 2025 — Present [monthly]

    Unknown

    Status: RecruitingUnknown

  2. Sep 2024 — Sep 2025 [monthly]

    Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  4. Aug 2023 — Jul 2024 [monthly]

    Recruiting

    First recorded

Mar 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • European Commission
  • European University Cyprus
  • PENTA Foundation
  • Servicio Madrileño de Salud, Madrid, Spain
  • University College, London
Data source: PENTA Foundation

For direct contact, visit the study record on ClinicalTrials.gov .